Obesity: Key Benefits and Insights for Integrative Care

Find out how integrative care for obesity combines diverse strategies for a comprehensive approach to weight management.

Abstract

In this educational post, I present an evidence-based, integrative roadmap for caring for adults living with obesity, focusing on the intricate connections between metabolic, reproductive, sleep, and psychiatric health. Drawing on leading research and my clinical experience, I will explain the considerations of polycystic ovary syndrome (PCOS), pregnancy-related risks, preconception care, sleep-related drivers of metabolic disease, and psychiatric comorbidities. I will provide actionable protocols using nutrition, physical activity, pharmacotherapy, and rehabilitative strategies. I will also describe how integrative chiropractic care fits alongside internal medicine oversight, functional medicine, and personal injury care within our multidisciplinary practice in El Paso, Texas. Our team-based model—led medically by Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine) and clinically integrated with my role as a chiropractor and family nurse practitioner—applies modern, evidence-based methods to improve metabolic, neuroendocrine, and musculoskeletal health for durable, generational outcomes.

About Our Multidisciplinary Clinic and Me in El Paso

I am Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. For decades, I have focused on integrative musculoskeletal and metabolic health, bridging chiropractic science, collaboration with internal medicine, and functional medicine to help patients with complex conditions, including obesity, PCOS, insulin resistance, chronic pain, and personal injury recovery.

Our clinic, Injury Medical Clinic PA (also known as Mission Plaza Injury Medical Clinic) in El Paso, Texas, operates in a multidisciplinary format common to integrative and injury care centers. Our Medical Director and Collaborative Physician, Dr. Maria Guadalupe Cardenas, MD, is Board Certified in Internal Medicine (NPI #1164426749, Texas MD License #J2933). With over 40 years of experience as an internist, Dr. Cardenas provides medical oversight, cardiometabolic risk management, medication stewardship, and diagnostic alignment. I coordinate integrative chiropractic care, rehabilitation, and functional medicine strategies in collaboration with her, especially for complex metabolic, cardiovascular, obstetric, and polypharmacy cases.

How Our Team Integrates Care

Our collaborative model allows us to address the whole person—their biochemistry, structure, and lifestyle—to create profound and lasting health transformations.

• Medical Oversight and Diagnostics (Dr. Cardenas): Cardenas directs medical evaluations, orders labs and imaging, manages comorbidities and cardiometabolic risk, monitors medication safety, and ensures continuity of integrated care.
• Integrative Chiropractic Care (Dr. Jimenez): I deliver spine and joint care, neuromuscular rehabilitation, and movement optimization to reduce pain, improve physical function, and increase activity tolerance—all essential for sustainable obesity care.
• Functional Medicine: We assess root-cause drivers such as insulin resistance, low-grade inflammation, sleep disruption, gut dysbiosis, and nutrient status to align personalized nutrition and lifestyle plans.
• Personal Injury Care: Post-collision or workplace injury often amplifies pain, inactivity, and weight gain. We use structured rehabilitation, ergonomics, and graded activity to re-enable movement.
• Behavioral and Psychiatric Support: We screen for depression, anxiety, and disordered eating, integrate counseling referrals, and align pharmacotherapy with behavioral strategies.
• Sleep Optimization: We evaluate for obstructive sleep apnea (OSA) and insomnia, aligning CPAP adherence, positional therapy, weight reduction, and circadian routines.
• Rehabilitation: We offer personal injury care, physical therapy, and targeted exercises to restore function and prevent future injuries.

Our protocols are grounded in current clinical guidelines and peer-reviewed literature, and they are continuously refined with outcomes from our practice and observations I share on ChiropracticScientist.com and my LinkedIn profile. The aim is to harmonize the metabolic, neuroendocrine, and musculoskeletal systems to achieve durable health change.

How Chronic Stress Drives Inflammation, Insulin Resistance, and Weight Gain

Chronic stress can begin early in life and influence every stage of health by driving low-grade inflammation, altering stress hormones, worsening sleep, and changing appetite signaling. When stress becomes persistent, the hypothalamic-pituitary-adrenal (HPA) axis increases cortisol production. Chronically activated cortisol signaling can impair metabolic flexibility, increase visceral fat storage, disrupt sleep, and contribute to insulin resistance.

From a physiological perspective, chronic stress may increase:

• Cortisol dysregulation
• Sympathetic nervous system activity
• Inflammatory cytokines, including interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-?)
• Cravings for highly palatable foods
• Abdominal adiposity
• Sleep fragmentation

This chronic inflammatory response can simmer for years. The relationship is bidirectional: excess adipose tissue, especially visceral fat, is metabolically active and releases inflammatory mediators, worsening insulin resistance. When chronic stress and obesity occur together, inflammation can amplify, creating a cycle where stress worsens sleep and cravings, poor sleep worsens appetite signaling, and weight gain worsens inflammation. Researchers have consistently shown that stress and sleep disruption influence metabolic health, appetite hormones, and obesity risk (St-Onge et al., 2016; Tomiyama, 2019).

Psychiatric Health, Sleep, Eating Patterns, and Weight Management

I view weight health, metabolic function, mental health, sleep quality, and musculoskeletal performance as interconnected systems. When I evaluate a patient, I consider whether psychiatric conditions may be contributing. Conditions such as depression, anxiety, post-traumatic stress disorder (PTSD), bipolar disorder, obsessive-compulsive disorder (OCD), ADD, and ADHD can influence appetite, motivation, sleep, and physical activity.

Screening is important, and I often use validated tools like the PHQ-9 for depression and GAD-7 for anxiety, coordinating with appropriate clinicians when a screen is positive. A patient with untreated depression may struggle with low motivation and emotional eating, while a patient with anxiety may experience insomnia and stress eating. Treating the underlying psychiatric condition can support both emotional and metabolic recovery.

Eating Disorders and Disordered Eating: Why Careful Screening Matters

Eating disorders are complex mental health conditions, not simple food choices. They can occur at any body size and include anorexia nervosa, bulimia nervosa, and binge eating disorder. I am careful with praise around weight loss, as it can unintentionally reinforce harm if a patient has a disordered eating pattern. Screening tools like the SCOFF questionnaire are essential.

Disordered eating, which may not meet full diagnostic criteria for an eating disorder, can involve problematic behaviors like rigid food rules or binge-restrict cycles. Management requires early support and referral. Anti-obesity medications may still be considered in selected patients, but the rationale must be carefully and individually tailored. The goal is metabolic stability, adequate nutrition, reduced shame, and safer eating patterns.

Sleep and Weight Health: Obstructive Sleep Apnea and Shift Work

Healthy sleep, typically seven to nine hours per night for adults, is restorative and supports appetite regulation, glucose metabolism, and immune function (Watson et al., 2015). When sleep is insufficient, hunger often increases, insulin sensitivity decreases, and energy for exercise is reduced.

• Obstructive Sleep Apnea (OSA): OSA occurs when the airway is temporarily blocked during sleep, causing oxygen levels to drop. Untreated OSA increases risk for hypertension, insulin resistance, and weight gain. We use screening tools such as the STOP-BANG questionnaire and refer patients for sleep studies when indicated. Interventions include CPAP, positional therapy, and weight loss. Recent research has shown that tirzepatide can lead to clinically meaningful reductions in apnea-hypopnea index and body weight in adults with obesity and moderate-to-severe OSA (Malhotra et al., 2024).
• Shift Work Disorder: This occurs when work schedules conflict with the body’s natural circadian rhythm, leading to chronic sleep loss and increased risk for weight gain, metabolic syndrome, and cardiovascular disease. Management includes consistent sleep schedules, light control, and careful timing of meals and caffeine intake.

Reproductive Health and PCOS in Adults 18–40

Polycystic Ovary Syndrome (PCOS) is the most common endocrine disorder among reproductive-age women and frequently coexists with obesity. It is a chronic, multisystem condition impacting reproductive, metabolic, and cardiovascular health.

What Underlies PCOS

• Insulin resistance (IR): IR is a primary driver, causing hyperinsulinemia that stimulates the ovaries to increase androgen synthesis. Elevated androgens disrupt follicle development, leading to oligo-ovulation or anovulation, acne, hirsutism, and androgenic alopecia. IR also contributes to dyslipidemia, type 2 diabetes, metabolic dysfunction-associated steatotic liver disease (MASLD), and low-grade inflammation (Dunaif, 2012).
• Obesity Synergy: Adiposity amplifies IR through adipokine imbalance and promotes visceral fat, which is particularly pro-inflammatory and worsens endocrine rigidity (Patel & Abate, 2022).

Diagnosis and Clinical Complications

We use the Rotterdam 2003 consensus criteria, which require at least two of the following: hyperandrogenism, ovulatory dysfunction, or polycystic ovarian morphology on ultrasound (Rotterdam criteria, 2003). Complications to anticipate include infertility, gestational diabetes, preeclampsia, endometrial cancer risk, MASLD, cardiovascular disease, and elevated rates of depression, anxiety, and eating disorders.

The Stakes: Why Maternal Metabolic Health Matters

From preconception through the postpartum period, maternal metabolic health shapes outcomes for both mother and baby. Women with gestational hypertension and preeclampsia face higher risks of miscarriage, preterm birth, and thromboembolism. These risks are magnified by pre-existing obesity and insulin resistance, which drive endothelial dysfunction. Obesity potentiates a pro-inflammatory cytokine milieu that worsens vascular function. Addressing this before conception is crucial.

Epigenetic and Generational Impact of Parental Adiposity

Both maternal and paternal adiposity increase offspring risk of obesity, cardiovascular disease, and type 2 diabetes. This occurs through epigenetic programming in utero, in which altered maternal glucose and lipid levels influence fetal DNA methylation, thereby shaping appetite regulation and insulin signaling (Hanson & Gluckman, 2019). Paternal obesity also contributes via sperm epigenetics (Donkin et al., 2016). We are not only caring for a pregnancy; we are influencing the metabolic destiny of future generations.

Evidence-Based Integrative Treatment Protocols

Our approach to managing obesity and its comorbidities is layered, starting with lifestyle foundations and adding targeted pharmacotherapy under medical oversight.

Preconception Weight Reduction

Lifestyle interventions can help mothers reduce pregnancy weight gain, and combining them with medications such as metformin or GLP-1/GIP receptor agonists can yield further reductions. The benefits of preconception weight reduction include lower fasting insulin levels, a 20–30% reduction in gestational diabetes, and a 20–40% reduction in macrosomia (ADA, 2024; ACOG, 2020/2022).

Nutrition: Managing Carbohydrate Intolerance and Insulin Spikes

Insulin resistance represents a spectrum of carbohydrate intolerance. Our approach emphasizes:

• Prioritizing protein (90–100 g/day) and fiber (50–100 g/day from vegetables and low-glycemic fruits) to enhance satiety and modulate glycemic load.
• Minimizing ultra-processed starches, sweets, and refined grains to reduce postprandial insulin surges.
• Favoring small, frequent meals over large ones to avoid large insulin peaks that promote fat storage and inhibit fat burning (Ludwig & Ebbeling, 2018).

Physical Activity: Short, Repeated Bouts and Resistance Work

We focus on metabolic conditioning rather than just calories burned:

• Three 10-minute brisk walks over the course of a day can produce greater insulin sensitization than a single 30-minute session in many patients, through repeated GLUT4 translocation events in skeletal muscle (Mikus et al., 2012).
• Resistance training 1–2 times weekly increases lean mass, raises resting metabolic rate, and improves insulin sensitivity.

Pharmacotherapy: Metformin and Advanced Obesity Medications

• Metformin: Off-label for non-diabetic PCOS with IR, it reduces hepatic gluconeogenesis and improves insulin signaling. We typically start with 500 mg extended-release daily and titrate slowly (Palomba et al., 2015).
• GLP-1 and GIP/GLP-1 Agonists: Drugs like semaglutide and tirzepatide improve satiety, slow gastric emptying, and enhance insulin secretion. They are discontinued before conception, with a recommended two-month washout period (Wilding et al., 2021; FDA, 2023–2025).
• Combination Therapy: For complex cases, we may use a combination of therapies like tirzepatide, phentermine, and topiramate to manage persistent hunger.
• Other Medications: Spironolactone can be used for acne and hirsutism (with contraception), and combined oral contraceptives protect the endometrium in women with irregular menses.

Breastfeeding: Maternal and Infant Health Benefits

Breastfeeding confers powerful benefits, including a lower risk of breast and ovarian cancer, type 2 diabetes, and cardiovascular disease for the mother. For the infant, it enhances immunity and reduces the risk of early obesity. However, women with obesity face barriers like difficult labor, delayed lactogenesis, and positioning difficulties. We provide proactive support, including early education, connection to lactation specialists, and ensuring adequate caloric intake to maintain milk supply.

Beyond Adjustments: Chiropractic and Integrative Healthcare- Video

How Integrative Chiropractic Care Fits In

As a chiropractor and functional medicine clinician, I incorporate neuromusculoskeletal strategies that complement medical management under Dr. Cardenas’s oversight. Pain is a major barrier to the physical activity necessary for metabolic health.

• Pain Modulation and Mobility: Many patients with obesity have lumbar facet irritation, sacroiliac joint dysfunction, and myofascial tightness. Targeted spinal manipulation, soft-tissue mobilization, and neuromuscular re-education reduce pain and facilitate adherence to graded exercise.
• Autonomic Balance: Gentle cervical and thoracic mobilization and breathing retraining can improve vagal tone, lower sympathetic overdrive, and positively affect sleep quality and appetite regulation.
• Pelvic Biomechanics and Posture: Chiropractic adjustments help optimize pelvic alignment, which reduces low back and pelvic girdle pain, improves gait, and supports core function, crucial both pre- and post-C-section.
• Rehabilitation Progression: We design graded activity plans aligned with metabolic capacity, starting with micro-sessions (e.g., sit-to-stand sets, marching) to build mitochondrial efficiency and joint resilience without flaring pain.

Case Studies: An Integrative Approach in Action

Case 1: “Alex” – A Multifaceted Approach to PCOS and Obesity

“Alex”, a patient with Class III obesity, PCOS, prediabetes, vitamin D deficiency, and several mental health conditions, presented a complex clinical picture. Her antidepressant, paroxetine, was weight-inducing, so we collaborated with her psychiatrist to switch to sertraline. Her treatment plan included metformin, vitamin D, semaglutide, a low-carbohydrate, protein-prioritizing diet, and starting with just ten minutes of enjoyable activity per day. Chiropractic care focused on reducing her chronic low back and joint pain to facilitate movement.

Results: After 6 months, Alex achieved a 15% reduction in total body weight, and her metabolic lab markers normalized. This demonstrates how an integrated approach targeting physical, metabolic, and mental health can achieve profound results.

Case 2: “Natasha” – Integrative Preconception-to-Postpartum Care

“Natasha”, a 33-year-old with Class III obesity, prediabetes, hypertension, and a history of preeclampsia, aimed to reduce weight before a second conception. Her two-year plan included a reduced-carb, high-protein/fiber diet, progressive physical activity, and medication management with metformin ER and tirzepatide. After reaching a BMI of 28.8 and normalizing her labs, we planned a two-month washout of tirzepatide before she attempted pregnancy. Chiropractic care focused on optimizing her pelvic biomechanics and core stability.

Results: Natasha conceived and had an uneventful pregnancy, successfully delivering via a planned C-section and establishing breastfeeding. This case highlights the power of sustained, proactive care across the reproductive timeline.

Case 3: “Devon” – A Marathon Approach to Long-Term Weight Management

“Devon”, a 40-year-old with Class III obesity, prediabetes, hypertension, and hyperlipidemia, required a long-term strategy. His plan included atorvastatin, metformin, and a restructured nutrition plan with meal replacements to correct his pattern of eating one large meal a day. Over time, his therapy evolved to a combination of tirzepatide, phentermine, and topiramate to manage persistent hunger. Chiropractic care was essential for alleviating the chronic pain that made his demanding job and intentional exercise difficult.

Results: After six years, Devon has maintained a 20% reduction in total body weight. His case illustrates that treating severe obesity is a chronic disease management process requiring patience, persistence, and a willingness to adapt the treatment plan over time.

Why This Integrated Model Works

Obesity is not merely excess weight—it is a complex metabolic, neuroendocrine, inflammatory, and mechanical condition. Addressing it demands synchronized care. Medical direction ensures safety and evidence alignment. Chiropractic care unlocks movement capacity and modulates pain and autonomic tone. Functional medicine personalizes nutritional and lifestyle drivers. Sleep and psychiatric care stabilize the behavioral and physiological foundations. This synergy reduces insulin resistance, corrects hormonal imbalances, improves sleep architecture, and restores functional movement, enabling durable health changes.

References

• ACOG Practice Bulletin: Gestational Hypertension and Preeclampsia. (2020/2022). American College of Obstetricians and Gynecologists.
• ADA Standards of Medical Care in Diabetes—2024. (2024). American Diabetes Association.
• Donkin, I., et al. (2016). Lancet Diabetes & Endocrinology: Paternal Obesity and Epigenetics. The Lancet Diabetes & Endocrinology.
• Dunaif, A. (2012). Insulin resistance and hyperandrogenism in PCOS: Review, PMC5301909.
• FDA Prescribing Information—Semaglutide, Tirzepatide, Phentermine. (2023–2025). U.S. Food and Drug Administration.
• Gaillard, R. (2015). Maternal obesity and fetal programming: PMC7333629.
• Garvey, W. T., et al. (2016). American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocrine Practice, 22(Suppl 3), 1-203.
• Hanson, M., & Gluckman, P. (2019). Developmental Origins of Health and Disease (DOHaD). Springer.
• Lévy, P., et al. (2020). OSA, intermittent hypoxia, and metabolism: PMC7497193.
• Ludwig, D. S., & Ebbeling, C. B. (2018). Meal size, insulin dynamics, and adiposity: PMC6520897.
• Malhotra, A., et al. (2024). Tirzepatide for the treatment of obstructive sleep apnea and obesity. The New England Journal of Medicine.
• Mikus, C. R., et al. (2012). Acute exercise bouts and insulin sensitivity: Journal of Applied Physiology. Journal of Applied Physiology.
• Miller, A. H., & Raison, C. L. (2016). Inflammation, mood, and metabolic links: PMC5944434.
• Moran, L. J., et al. (2017). Weight loss and ovulation restoration in PCOS: PMC6074509.
• Palomba, S., et al. (2015). Metformin mechanisms in PCOS: PMC4560204.
• Patel, S., & Abate, N. (2022). Visceral adiposity, adipokines, and inflammation: Review, PMC9644354.
• Rotterdam criteria for PCOS: Human Reproduction, 2003. (2003). Human Reproduction.
• St-Onge, M. P., et al. (2016). Sleep duration and quality: Impact on lifestyle behaviors and cardiometabolic health. Circulation.
• Tomiyama, A. J. (2019). Stress and obesity. Annual Review of Psychology, 70, 703-718.
• Watson, N. F., et al. (2015). Recommended amount of sleep for a healthy adult: A joint consensus statement of the American Academy of Sleep Medicine and Sleep Research Society. Sleep, 38(6), 843-844.
• Wilding, J. P. H., et al. (2021). GLP-1 receptor agonists for obesity: NEJM. New England Journal of Medicine.

SEO tags: obesity care, PCOS treatment, insulin resistance, GLP-1, tirzepatide, metformin, sleep apnea, pregnancy and obesity, preconception counseling, integrative chiropractic, functional medicine, internal medicine collaboration, El Paso clinic, Dr Alex Jimenez, Dr Maria Guadalupe Cardenas, metabolic health, rehabilitation, personal injury, weight loss, reproductive health, maternal metabolic health, gestational hypertension, preeclampsia, epigenetics, breastfeeding benefits, postpartum recovery, stress and obesity, eating disorders and obesity, binge eating disorder, psychiatric health and metabolism, chronic inflammation, multidisciplinary injury clinic, El Paso chiropractic functional medicine